Menu

Search

Nathan Bartlett

Nathan Bartlett

Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
Nathan Bartlett is Associate Professor and head of the Viral Immunology and Respiratory Disease group and is based at the Hunter Medical Research Institute. He also retains an honorary academic appointment at Imperial College London, UK to continue collaborative research.

Following the award of PhD, Dr Bartlett undertook a 5 year Postdoctoral research position, first at the Sir William Dunn School of Pathology, University of Oxford, then in the Department of Virology, Imperial College London. Dr Bartlett then undertook a second Postdoctoral position in the Department of Respiratory Medicine within the National Heart and Lung Institute (NHLI), also at Imperial.

After joining the NHLI, Dr Bartlett continued to build on his virology training leading to Bartlett et al, Nature Medicine 2008, the world's first mouse rhinovirus infection model. He has investigated the interaction of respiratory viral infection with type-2 immunity to uncover pathogenic mechanisms in asthma exacerbations. He was a co-applicant on several successful project and program grants and since his Lecturer appointment at Imperial in 2011 was successful as the Lead Investigator in achieving an MRC project grant to study the role of IL-25 in asthma exacerbations, the research from which was published as the featured cover story in Science Translational Medicine (October 2014). Dr Bartlett has contributed to several scholarly books including the Rhinovirus chapter for the Encyclopaedia of Virology (Elsevier) and ,edited Rhinovirus Infections: Rethinking Impact on Human Health and Disease (Elsevier). Dr Bartlett is considered a world expert on in vivo and human airway epithelial models of rhinovirus infection and consults for a number companies that are bringing novel therapies for respiratory infection and inflammatory airways diseases to the clinic.He is also an Associate Editor for the American Journal of Physiology - Lung, Cellular and Molecular Physiology (AJP-LUNG) and a member of the European Respiratory Society College of Experts.

In 2015 Dr Bartlett accepted an academic appointment at the University of Newcastle where he has received funding from HMRI, Asthma Australia, NH&MRC and multiple Industry Partners and associated Government grants. He work has led to the publishing of multiple patents related to treatments currently in development for respiratory virus infections and exacerbations of chronic respiratory diseases.

He is now exploring novel therapies and treatments to fight COVID-19, a novel coronavirus which was declared a pandemic in March 2020. His team is exploring a range of anti-viral options for this virus, partnering with other researchers to explore different methods to fight the virus. For example Dr Bartlett is working with Professor Hubert Hondermarck to assess the safety and efficacy of a range of cancer drugs which have the potential to be repurposed.

Dr Bartlett continues to work with Ena Therapeutics (MRCF-funded company) who have developed an innate immune stimulant that protects the lungs against respiratory virus infections. Boosting lung innate immunity bridges the gap between vaccine mediated long term protection and anti-viral drug to treat active infection. He is now using coronavirus infections models to determine the efficacy of this approach.

He is also helping local industries that are focusing their business to produce disinfectants, sanitizers and virus inactivating materials that will become part of everyday life as we adapt to coexist with new respiratory viruses such as SARS-CoV-2.

What if I can't get in for my second Pfizer dose and the gap is longer than 3 weeks?

Jun 20, 2021 11:57 am UTC| Health

Bookings for the first dose of the Pfizer vaccine have been halted in Victoria this week, amid shortages of the vaccine. Some Victorians whove had their first Pfizer dose already will need to wait six weeks to get their...

The Pfizer vaccine may not be the best choice for frail people, but it's too early to make firm conclusions

Jan 19, 2021 05:48 am UTC| Health

Reports of about 30 deaths among elderly nursing home residents who received the Pfizer vaccine have made international headlines. With Australias Therapeutic Goods Administration (TGA) expected to approve the vaccine...

1 

Economy

Coinbase drops lending program due to SEC's lawsuit threat

Coinbase dropped its plan to launch a lending program after the US Securities and Exchange Commission (SEC) threatened it with a lawsuit The Nasdaq-listed cryptocurrency exchange said that as it continues to seek...

Nike retains top spot among most marketable sports brands for 2021

US sportswear giant Nike has retained the top spot in SportsPros list of the Worlds 50 Most Marketable (50MM) brands, holding off challenges by rival sportswear brand and second-placer Adidas, Emirates, Santander, and Red...

Michael Jordan raises stake, assumes adviser role in sports gambling firm Sportradar

NBA legend Michael Jordan will increase his investment in Sportradar Group AG, the leading global provider of sports betting and entertainment products and services, and will serve as a special adviser to the companys...

UK industry group warns CO2 crisis poses a risk of meat shortage

An industry group has warned of carbon dioxide (CO2) shortage in the UK within the week due to a sharp rise in gas prices that could result in meat supply issues. The gas price hie has forced domestic energy suppliers...

Cargill to pay farmers $20 per metric ton of carbon emissions reduced

Cargill is planning to pay farmers $20 per metric ton of carbon emissions they reduce through regenerative agricultural practices. The company intends to pass the green credits on to its customers. The Cargill...

Politics

Nancy Pelosi, G7 Speakers visit 'Coronation Street' set following summit

US House Speaker Nancy Pelosi was among her fellow presiding officers in the G7 in attendance at the summit in the United Kingdom. Following the summit, the group was shown around the set of the popular British tv series...

Joe Biden: Former Israeli PM Benjamin Netanyahu mocks widely debunked manipulated video of POTUS

A manipulated video showing US President Joe Biden seemingly falling asleep during his meeting with the new Israeli Prime Minister Naftali Bennett made the rounds on right-wing social media. The manipulated video also...

Capitol insurrection: Former aide to Mike Pence says ex-VP is as responsible for the political violence

Former vice president Mike Pence was among the individuals being targeted by the pro-Trump mob that stormed the Capitol last January 6. However, despite Pences inevitable refusal to overturn the electoral results, Pences...

Kamala Harris to appear on 'The View' this week

This week, Vice President Kamala Harris will be making another stop by the popular daytime talk show, The View. Harris will be making her first appearance on the show as vice president on Friday. Harris will be...

Science

S. Korea's POSCO, Hyundai to use oyster shell waste for steelmaking

S. Korean steelmakers POSCO and Hyundai Steel Co. will start using oyster shells as a secondary base material for producing steel. Both firms have been developing a recycling technology with a local oyster shell...

S. Korea to develop solar-powered drone that could carry 20 kg to stratosphere

South Korea will invest 37.47 billion won in developing a solar-powered drone that could carry over 20 kilograms in the stratosphere and with natural disaster monitoring capability by 2025. The drone will serve as an...

S. Korean scientists develop 3D printing ink from sunflower pollen

A group of South Korean scientists from Nanyang Technological University in Singapore managed to develop 3D printing ink material from sunflower pollen. The research team led by professor Cho Nam-joon first incubated...

Kumho Petrochemical to produce eco-friendly rubber compound out of rice bran

Kumho Petrochemical Co. will produce an eco-friendly synthetic rubber compound made of rice bran-based bio-silica. Silica improves fuel efficiency, braking power, and wear resistance of synthetic rubber for...

From CRISPR to glowing proteins to optogenetics – scientists' most powerful technologies have been borrowed from nature

Watson and Crick, Schrdinger and Einstein all made theoretical breakthroughs that have changed the worlds understanding of science. Today big, game-changing ideas are less common. New and improved techniques are the...

Technology

Telegram update introduces new themes for private chats

The latest update on Telegram appears to be focused on giving users more options to customize their chats. People can now apply new themes to private chats, as well as use animated emojis and enable read receipts for group...

OnePlus 9T will not be released this year

To those waiting for the OnePlus 9T, it is time to reconsider their smartphone upgrade plans. The company recently announced the device is not in the pipeline. For years, OnePlus has had two major smartphone launch...

Google Pixel foldable phone codenamed ‘Passport’ will reportedly launch in late 2021

Talks about Googles rumored foldable smartphone have been renewed recently after a couple of potential clues surfaced online. Now, a long-time renowned leaker has weighed in, reporting that a device codenamed Passport is...

‘League of Legends’ will have heavier punishments for repeat ‘leavers’ and AFK offenders

Abruptly leaving a match or moving away from the keyboard (AFK) could affect other players, especially in online multiplayer games like League of Legends. So for repeat offenders, Riot Games confirmed it is planning to...

Samsung Galaxy S22 benchmark test hints at the use of Snapdragon 898 SoC

A Geekbench test result reportedly done for a device believed to be Samsung Galaxy S22 has appeared in the wild. And it could be one of the earliest confirmations that it will be powered by the upcoming Snapdragon 898 SoC,...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.